|
No records
|
|
105 |
Akmal M.M., Pabittei D.R., Prapassaro T., Suhartono R., Moll F.L., van Herwaarden J.A. |
57212520722;36722034600;57205214358;57218884615;7103009095;6602663510; |
A systematic review of the current status of interventions for type II endoleak after EVAR for abdominal aortic aneurysms |
2021 |
International Journal of Surgery |
95 |
|
106138 |
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117194344&doi=10.1016%2fj.ijsu.2021.106138&partnerID=40&md5=04d622b377ba196029ff5e68c6be3e4c |
Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands; Vascular surgery Division, Departement of Surgery, Faculty of Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Indonesia; Departement of Physiology, Hasanudin University, Indonesia; Departement of vascular surgery, Siriraj Hospital, Mahidol UniversityBangkok, Thailand |
Akmal, M.M., Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands, Vascular surgery Division, Departement of Surgery, Faculty of Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Indonesia; Pabittei, D.R., Departement of Physiology, Hasanudin University, Indonesia; Prapassaro, T., Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands, Departement of vascular surgery, Siriraj Hospital, Mahidol UniversityBangkok, Thailand; Suhartono, R., Vascular surgery Division, Departement of Surgery, Faculty of Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Indonesia; Moll, F.L., Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands; van Herwaarden, J.A., Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands |
Objective: To study the mid- and long-term outcomes of type II endoleak treatment after EVAR and the technical aspects of different techniques to exclude endoleaks which different embolic agents. Methods: A systematic review was performed using the approach recommended by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for meta-analyses of interventional studies. The comprehensive search was conducted using the following database: MEDLINE, EMBASE, and the Cochrane Library. Patient characteristic, intervention approaches, embolic agents, and results at mid and long term follow up were studied. Results: A total of 6 studies corresponding to a total of 141 patients fulfilled the inclusion criteria with a mean age of 73–78.6 years and a mean duration of follow up varying from 25 to 42 months. There were different techniques for embolization used (translumbar, transarterial, and transcaval approach) with various types of embolic agents. In all studies, the indication for embolization of the type II endoleaks was sac enlargement of more than 5 mm. A wide range of technical success rate was reported regardless of the intervention strategy being used (17,6%–100%). The overall technical success rate of all studies was 62%. Conclusion: This systematic review shows that there is a wide variety of techniques to exclude a persistent type II endoleak. Different kinds of embolic agents have be used. Due to a lack of peer reviewed data on longterm follow-up, it was not possible to come to recommendations what treatment would be the best for a durable exclusion of a persistent type II endoleak after an initially successful EVAR. There remains an urgent need for proper executed studies, either randomized or with close observation in relation to longer follow-up. © 2021 The Authors |
Abdominal aorta aneurysm; Aneurysm repair; Endoleaks; Endovascular aneurysm repair; Type |
ethylene vinyl alcohol copolymer; glue; iodinated poppyseed oil; onyx copolymer; thrombin; abdominal aortic aneurysm; aged; artificial embolization; clinical outcome; cohort analysis; conservative treatment; data extraction; endoleak; endovascular aneurysm repair; follow up; human; laparoscopic surgery; major clinical study; meta analysis; outcome assessment; postoperative infection; practice guideline; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; quality control; Review; selective transcaval embolization; surgical approach; systematic review; transarterial embolization; translumbar embolization; treatment duration; treatment indication; type ii endoleak; very elderly; adverse event; artificial embolization; endoleak; endovascular surgery; Aged; Aortic Aneurysm, Abdo |
Elsevier Ltd |
17439191 |
|
34637951 |
Review |
Q1 |
1315 |
2831 |
|
|
|
110 |
Abdullah M., Sukartini N., Nursyirwan S.A., Pribadi R.R., Maulahela H., Utari A.P., Muzellina V.N., Wiraatmadja A., Renaldi K. |
7103393434;6505680329;57249143800;57194732282;57189612709;57113585900;57223968527;57249709700;57190963547; |
Gut Microbiota Profiles in Early-and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future |
2021 |
Digestion |
102 |
6 |
|
823 |
832 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114428104&doi=10.1159%2f000516689&partnerID=40&md5=b8c0c7b633dbb180aa40d5f20e5481d7 |
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Human Cancer Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Department of Clinical Pathology, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
Abdullah, M., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia, Human Cancer Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Sukartini, N., Department of Clinical Pathology, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Nursyirwan, S.A., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Pribadi, R.R., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Maulahela, H., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Utari, A.P., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Muzellina, V.N., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Wiraatmadja, A., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Renaldi, K., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
Background: Researchers believe the role of gut microbiota dysbiosis in the raised incidence of early-onset colorectal cancer (EOCRC). The development of EOCRC may be associated with microbiota dysbiosis either dependently or independently (combined with other risk factors). Summary: Recently, the rising of incidence and mortality of EOCRC have been noted. Some researchers are looking for risk factors influencing this fact. They hypothesize that it may be because of microbiota dysbiosis. Microbiota dysbiosis has been known to promote cancer development through immunity dysregulation and chronic inflammation. Microbiomes profile in late-onset colorectal cancer (LOCRC) among older patients has been documented, but there is still lack of data about microbial profiles among younger colorectal cancer (CRC) patients. This review tries to explain microbial profiles differences between EOCRC and LOCRC as a potential diagnostic biomarker in the future, and whether microbiota can have a role in EOCRC genesis. Key Messages: Microbiota does vary with age, and EOCRC may be associated with colonization of some specific bacteria. Further studies about gut microbiota profiles in EOCRC and LOCRC may provide a new insight on diagnostic biomarker of CRC. © 2021 S. Karger AG, Basel. Copyright: All rights reserved. |
Colorectal cancer; Diagnostic biomarker; Early-onset colorectal cancer; Gut microbiota; Microbiota dysbiosis |
biological marker; colorectal tumor; dysbiosis; human; incidence; intestine flora; Biomarkers; Colorectal Neoplasms; Dysbiosis; Gastrointestinal Microbiome; Humans; Incidence |
S. Karger AG |
00122823 |
|
34433172 |
Review |
Q2 |
882 |
5279 |
|
|
|
138 |
Gunardi T.H., Susantono D.P., Victor A.A., Sitompul R. |
57195939686;57353411000;57191055282;8312163900; |
Atopobiosis and dysbiosis in ocular diseases: Is fecal microbiota transplant and probiotics a promising solution? |
2021 |
Journal of Ophthalmic and Vision Research |
16 |
4 |
|
631 |
643 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119915775&doi=10.18502%2fJOVR.V16I4.9754&partnerID=40&md5=8d0e2b295a398c85ff1c28564276103b |
Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Ophthalmology, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Gunardi, T.H., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Susantono, D.P., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Victor, A.A., Department of Ophthalmology, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Sitompul, R., Department of Ophthalmology, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Purpose: To highlight the role of atopobiosis and dysbiosis in the pathomechanism of autoimmune uveitis, therefore supporting fecal microbiota transplant (FMT) and probiotics as potential targeted-treatment for uveitis. Methods: This review synthesized literatures upon the relation between gut microbiota, autoimmune uveitis, FMT, and probiotics, published from January 2001 to March 2021 and indexed in PubMed, Google Scholar, CrossRef. Results: The basis of the gut-eye axis revolves around occurrences of molecular mimicry, increase in pro-inflammatory cytokines, gut epithelial barrier disruption, and translocation of microbes to distant sites. In patients with autoimmune uveitis, an increase of gut Fusobacterium and Enterobacterium were found. With current knowledge of aforementioned mechanisms, studies modifying the gut microbiome and restoring the physiologic gut barrier has been the main focus for pathomechanism-based therapy. In mice models, FMT and probiotics targeting repopulation of gut microbiota has shown significant improvement in clinical manifestations of uveitis. Consequently, a better understanding in the homeostasis of gut microbiome along with their role in the gut-eye axis is needed to develop practical targeted treatment. Conclusion: Current preliminary studies are promising in establishing a causative gut-eye axis relationship and the possibility of conducting FMT and probiotics as targeted treatment to mitigate autoimmune uveitis, to shorten disease duration, and to prevent further complications. © 2021 GUNARDI ET AL. THIS IS AN OPEN ACCESS ARTICLE DISTRIBUTED UNDER THE CREATIVE COMMONS ATTRIBUTION LICENSE | PUBLISHED BY KNOWLEDGE E |
Atopobiosis; Autoimmune; Dysbiosis; Gut-Eye Axis; Uveitis |
|
Knowledge E |
20082010 |
|
|
Review |
Q3 |
557 |
9058 |
|
|
|
143 |
Djaali W., Mihardja H., Viventius Y., Teja Y., Bunawan H.L., Setiawan M., Yunita L. |
57212479564;57195721818;57223088537;57325017200;57324454000;57324269700;57324454100; |
The Role of Acupuncture in Interventional Pain Management |
2021 |
Medical Acupuncture |
33 |
5 |
|
329 |
334 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118530798&doi=10.1089%2facu.2021.0004&partnerID=40&md5=7d65d90740d49223d9332a2572c084c0 |
Department of Medical Acupuncture, RSUPN Dr. Cipto Mangunkusumo, Central Jakarta, Indonesia; Medical Acupuncture Specialist Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Universitas Negeri Jakarta, East Jakarta, DKI Jakarta, Indonesia; Center for the Development and Application of Traditional Medicine of DKI Jakarta, Jakarta, Indonesia |
Djaali, W., Department of Medical Acupuncture, RSUPN Dr. Cipto Mangunkusumo, Central Jakarta, Indonesia, Medical Acupuncture Specialist Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Universitas Negeri Jakarta, East Jakarta, DKI Jakarta, Indonesia; Mihardja, H., Department of Medical Acupuncture, RSUPN Dr. Cipto Mangunkusumo, Central Jakarta, Indonesia, Center for the Development and Application of Traditional Medicine of DKI Jakarta, Jakarta, Indonesia; Viventius, Y., Department of Medical Acupuncture, RSUPN Dr. Cipto Mangunkusumo, Central Jakarta, Indonesia, Medical Acupuncture Specialist Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Teja, Y., Department of Medical Acupuncture, RSUPN Dr. Cipto Mangunkusumo, Central Jakarta, Indonesia, Medical Acupuncture Specialist Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Bunawan, H.L., Department of Medical Acupuncture, RSUPN Dr. Cipto Mangunkusumo, Central Jakarta, Indonesia, Medical Acupuncture Specialist Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Setiawan, M., Department of Medical Acupuncture, RSUPN Dr. Cipto Mangunkusumo, Central Jakarta, Indonesia, Medical Acupuncture Specialist Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Yunita, L., Department of Medical Acupuncture, RSUPN Dr. Cipto Mangunkusumo, Central Jakarta, Indonesia, Medical Acupuncture Specialist Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Objective: Interventional pain management has been recognized over the last couple of decades for treating chronic-pain syndromes. Acupuncture is a nonpharmacologic therapeutic option for pain management and may be an option for different patients with contraindications for interventional pain management. This review explores this options. Method: This limited review examines the role of acupuncture for managing head-and-neck pain and lower-back pain, according to interventional pain management. Conclusions: Acupuncture at various points, corresponding to the stellate ganglion, which is ST 10 Shuitu, and corresponding to the splanchnic nerve and the facet joint of the lumbar vertebra - which are Ex-B2 paravertebra - can be applied for pain management in the head-and-neck area and in the lower-back area. According to various research findings, acupuncture is effective and safe for reducing pain in the head and neck area, as well as in the lower back. © Copyright 2021, Mary Ann Liebert, Inc., publishers 2021. |
acupuncture; head-and-neck pain; interventional pain management; lower-back pain |
acupuncture analgesia; headache; human; interventional pain management; intervertebral articulation; low back pain; neck pain; nerve block; neuroanatomy; paraspinal muscle; Review; shuitu acupoint; splanchnic nerve; stellate ganglion; stellate ganglion block |
Mary Ann Liebert Inc. |
19336586 |
|
|
Review |
Q2 |
281 |
15498 |
|
|
|
150 |
Basrowi R.W., Rahayu E.M., Khoe L.C., Wasito E., Sundjaya T. |
57024210400;57275241200;56586245200;6506940239;57188810826; |
The road to healthy ageing: What has indonesia achieved so far? |
2021 |
Nutrients |
13 |
10 |
3441 |
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115825022&doi=10.3390%2fnu13103441&partnerID=40&md5=71597249210e18c8c5775dcf67e18dbe |
Occupational Medicine Division, Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Medical and Science Affairs Division, Danone Specialized Nutrition Indonesia, Jakarta, 12950, Indonesia; Department of Anthropology, Faculty of Social and Political Science Universitas Indonesia, Depok, 16424, Indonesia; Laboratorium Political Psychology, Faculty of Psychology Universitas Indonesia, Depok, 16424, Indonesia |
Basrowi, R.W., Occupational Medicine Division, Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia, Medical and Science Affairs Division, Danone Specialized Nutrition Indonesia, Jakarta, 12950, Indonesia; Rahayu, E.M., Department of Anthropology, Faculty of Social and Political Science Universitas Indonesia, Depok, 16424, Indonesia, Laboratorium Political Psychology, Faculty of Psychology Universitas Indonesia, Depok, 16424, Indonesia; Khoe, L.C., Occupational Medicine Division, Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Wasito, E., Medical and Science Affairs Division, Danone Specialized Nutrition Indonesia, Jakarta, 12950, Indonesia; Sundjaya, T., Medical and Science Affairs Division, Danone Specialized Nutrition Indonesia, Jakarta, 12950, Indonesia |
The World Health Organization (WHO) has projected that the world should prepare for an aging society. As the fourth most populous country in the world, the elderly population in Indonesia is also continuously growing. In 2010, the proportion of the elderly group was merely 5%, and it is expected to increase to 11% in 2035. Understanding the current situation of the adult population in Indonesia would be crucial to prepare for the future aging population. This article analyzed the current socio-demographic status, nutrition status, nutrient intake, and health profile of the current Indonesian adult population through a literature review. The key issues to prepare for healthy aging in Indonesia are summarized. Acknowledging the profile of the adult and senior adult population in Indonesia will provide beneficial information for all stakeholders in preparing Indonesia for a better healthy aging population with improved quality of life. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. |
Aging population; Demographic; Health profile; Healthy ageing; Nutritional status |
adult; aged; demography; female; healthy aging; human; human experiment; Indonesia; Indonesian; male; nutrient intake; nutritional status; quality of life; review; World Health Organization; epidemiology; health status; health survey; Indonesia; nutritional status; socioeconomics; Health Status; Healthy Aging; Humans; Indonesia; Nutritional Status; Public Health Surveillance; Quality of Life; Socioeconomic Factors |
MDPI |
20726643 |
|
34684441 |
Review |
Q1 |
1418 |
2497 |
|
|
|
165 |
Vandenplas Y., Hegar B., Munasir Z., Astawan M., Juffrie M., Bardosono S., Sekartini R., Basrowi R.W., Wasito E. |
57223670656;6506273944;7801694370;55622754000;6603321832;21933841000;57224503576;57024210400;6506940239; |
The role of soy plant-based formula supplemented with dietary fiber to support children's growth and development: An expert opinion |
2021 |
Nutrition |
90 |
|
111278 |
|
|
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85106303526&doi=10.1016%2fj.nut.2021.111278&partnerID=40&md5=6f39985da49e44dfd1fa5832b4927b0a |
KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Belgium; Department of Pediatric, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General HospitalJakarta, Indonesia; Department of Food Science and Technology, IPB University, Bogor, Indonesia; Department of Child Health, Faculty of Medicine, Universitas Gajah MadaYogyakarta, Indonesia; Department of Nutrition, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General HospitalJakarta, Indonesia; Danone Specialized Nutrition IndonesiaJakarta, Indonesia |
Vandenplas, Y., KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Belgium; Hegar, B., Department of Pediatric, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General HospitalJakarta, Indonesia; Munasir, Z., Department of Pediatric, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General HospitalJakarta, Indonesia; Astawan, M., Department of Food Science and Technology, IPB University, Bogor, Indonesia; Juffrie, M., Department of Child Health, Faculty of Medicine, Universitas Gajah MadaYogyakarta, Indonesia; Bardosono, S., Department of Nutrition, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General HospitalJakarta, Indonesia; Sekartini, R., Department of Pediatric, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General HospitalJakarta, Indonesia; Basrowi, R.W., Danone Specialized Nutrition IndonesiaJakarta, Indonesia; Wasito, E., Danone Specialized Nutrition IndonesiaJakarta, Indonesia |
Objectives: Soy-based formula has evolved in usage and processing technology since its introduction in 1909, and has been used as substitute formula for infants or children with cow milk allergy since 1929. At present, personal opinions, religious background, availability, palatability, and cost are part of the reasons soy-based formula is chosen. Technology in processing soy-based formula has evolved from using soy flour to soy protein isolate, which provides advantages. However, concerns remain regarding the impact of its use on the growth and development of children. Methods: An expert meeting, attended by 12 experts, was initiated in Jakarta, Indonesia, to obtain an evidence-based consensus on the role of soy protein isolate formula, as well as its nutritional value to support growth and development. Results: Ensuring that plant-based formula (i.e., soy protein isolate formula) is fortified with key nutrients, such as calcium, iron, and dietary fiber is important. Conclusions: Consensus was achieved, concluding that soy protein isolate formula is safe, affordable, and an alternative option for cow's milk–based formula for term infants. © 2021 The Authors |
Child growth and development; Expert opinion; Soy-based infant formula |
calcium; iron; soybean protein; artificial milk; child growth; developmental stage; diet supplementation; dietary fiber; human; nutritional value; patient safety; priority journal; Review; soybean; soybean meal; animal; artificial milk; bovine; child; dietary fiber; expert witness; female; infant; milk allergy; Animals; Cattle; Child; Dietary Fiber; Expert Testimony; Female; Humans; Infant; Infant Formula; Milk Hypersensitivity; Soybean Proteins |
Elsevier Inc. |
08999007 |
|
34004412 |
Review |
Q2 |
1002 |
4372 |
|
|
|
167 |
Nunan D., Lindblad A., Widyahening I.S., Bernardo W.M., Chi C.-C., Cowdell F., Becker K., Constantine S., East C., Myrhaug H.T., Johnson S.G., Jack E., Thompson R., Achilleos H., Berg R.C., Snibsøer A.K., Puscasiu L., Bartelink M.-L.E.L., Van Peet P.G., Berti F., Tilson J., Tikkinen K.A.O., Albarqouni L., Hoegen P. |
23976859100;56106404200;54893154400;6507335779;8642372600;8608168300;57219926978;57219929038;57219925201;56503684400;57216536721;57204240840;55763226900;57204277188;24721440500;57193017204;25929536400;6701351200;55270285900;7102391287;23490405400;11142330400;57193204115;57219924120; |
Ten papers for teachers of evidence-based medicine and health care: Sicily workshop 2019 |
2021 |
BMJ Evidence-Based Medicine |
26 |
5 |
|
224 |
227 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096121852&doi=10.1136%2fbmjebm-2020-111479&partnerID=40&md5=f59cb3d2d628fd79e4b11778bafd8318 |
Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom; Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom; Alberta College of Family Physicians (PEER), The Department of Family Medicine, University of Alberta, Edmonton, AB, Canada; Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil; Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; School of Nursing and Midwifery, Faculty of Health, Education and Life Sciences, Birmingham City University, Birmingham, United Kingdom; Family and Social Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States; Internal Medicine, Sapporo Tokushukai Hospital, Sapporo, Japan; School of Nursing and Midwifery and Mercy Health, La Trobe University College of Science Health and Engineering, Bundoora, VIC, Australia; Division for Health Sciences, Norwegian Institute of Public Health, Oslo, Norway; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway; Department of Health and Functioning, Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway; Yealm Medical Centre, Yealmton, United Kingdom; PenARC (NIHR) Applied Research Collaboration (ARC) South West Peninsula, Exeter, United Kingdom; Office of Medical Education, University of New South Wales, Sydney, NSW, Australia; Paediatrics, Royal London Hospital Barts Health Nhs Trust, London, United Kingdom; Reviews and Health Technology Assessments, Norwegian Institute of Public Health, Oslo, Norway; Health and Caring Sciences, Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway; University of Medicine Pharmacy Science and Technology of Targu Mures, Targu Mures, Romania; General Practice, Julius Centre, Umc Utrecht, Utrecht, Netherlands; Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands; Gruppo Italiano per la Medicina Basata Sulle Evidenze (GIMBE), Bologna, Italy; Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, CA, United States; Departments of Urology and Public Health, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; Department of Surgery, South Karelia Central Hospital, Lappeenranta, Finland; Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia; School of Health and Social Care, Avans University of Applied Science, Breda, Netherlands |
Nunan, D., Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom, Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom; Lindblad, A., Alberta College of Family Physicians (PEER), The Department of Family Medicine, University of Alberta, Edmonton, AB, Canada; Widyahening, I.S., Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Bernardo, W.M., Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil; Chi, C.-C., Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, College of Medicine, Chang Gung University, Taoyuan, Taiwan; Cowdell, F., School of Nursing and Midwifery, Faculty of Health, Education and Life Sciences, Birmingham City University, Birmingham, United Kingdom; Becker, K., Family and Social Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States; Constantine, S., Internal Medicine, Sapporo Tokushukai Hospital, Sapporo, Japan; East, C., School of Nursing and Midwifery and Mercy Health, La Trobe University College of Science Health and Engineering, Bundoora, VIC, Australia; Myrhaug, H.T., Division for Health Sciences, Norwegian Institute of Public Health, Oslo, Norway, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway; Johnson, S.G., Department of Health and Functioning, Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway; Jack, E., Yealm Medical Centre, Yealmton, United Kingdom, PenARC (NIHR) Applied Research Collaboration (ARC) South West Peninsula, Exeter, United Kingdom; Thompson, R., Office of Medical Education, University of New South Wales, Sydney, NSW, Australia; Achilleos, H., Paediatrics, Royal London Hospital Barts Health Nhs Trust, London, United Kingdom; Berg, R.C., Reviews and Health Technology Assessments, Norwegian Institute of Public Health, Oslo, Norway; Snibsøer, A.K., Health and Caring Sciences, Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway; Puscasiu, L., University of Medicine Pharmacy Science and Technology of Targu Mures, Targu Mures, Romania; Bartelink, M.-L.E.L., General Practice, Julius Centre, Umc Utrecht, Utrecht, Netherlands; Van Peet, P.G., Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands; Berti, F., Gruppo Italiano per la Medicina Basata Sulle Evidenze (GIMBE), Bologna, Italy; Tilson, J., Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, CA, United States; Tikkinen, K.A.O., Departments of Urology and Public Health, University of Helsinki, Helsinki University Hospital, Helsinki, Finland, Department of Surgery, South Karelia Central Hospital, Lappeenranta, Finland; Albarqouni, L., Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia; Hoegen, P., School of Health and Social Care, Avans University of Applied Science, Breda, Netherlands |
[No abstract available] |
evidence-based practice; health; patient care |
consensus; Delphi study; ethnographic research; evidence based medicine; evidence based practice; health care; health practitioner; human; interview; knowledge management; medical education; patient; patient care; physician; practice guideline; primary medical care; publication; Review; risk factor; risk reduction; shared decision making; Sicily; systematic review (topic); teacher; workshop; health care delivery; Delivery of Health Care; Evidence-Based Medicine; Humans; Sicily |
BMJ Publishing Group |
2515446X |
|
33172938 |
Review |
Q2 |
676 |
7397 |
|
|
|
176 |
Nakhaei P., Margiana R., Bokov D.O., Abdelbasset W.K., Jadidi Kouhbanani M.A., Varma R.S., Marofi F., Jarahian M., Beheshtkhoo N. |
57226413840;56685900600;56845561300;57208873763;57219274421;7201793587;57199650994;16241593900;57201547070; |
Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol |
2021 |
Frontiers in Bioengineering and Biotechnology |
9 |
|
705886 |
|
|
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115653337&doi=10.3389%2ffbioe.2021.705886&partnerID=40&md5=0d6cee3ed2be3a97e6c2beb3d6c668b5 |
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Cipto Mangunkusumo Hospital, The National Referral Hospital, Central Jakarta, Indonesia; Master’s Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Institute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russian Federation; Laboratory of Food Chemistry, Federal Research Center of Nutrition, Biotechnology, and Food Safety, Moscow, Russian Federation; Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia; Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt; Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Czech Republic; Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacký University in Olomouc, Olomouc, Czech Republic; Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; Toxicology and Chemotherapy Unit (G401), German Cancer Research Center, Heidelberg, Germany |
Nakhaei, P., School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Margiana, R., Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia, Cipto Mangunkusumo Hospital, The National Referral Hospital, Central Jakarta, Indonesia, Master’s Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Bokov, D.O., Institute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russian Federation, Laboratory of Food Chemistry, Federal Research Center of Nutrition, Biotechnology, and Food Safety, Moscow, Russian Federation; Abdelbasset, W.K., Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia, Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt; Jadidi Kouhbanani, M.A., Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Czech Republic; Varma, R.S., Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacký University in Olomouc, Olomouc, Czech Republic; Marofi, F., Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; Jarahian, M., Toxicology and Chemotherapy Unit (G401), German Cancer Research Center, Heidelberg, Germany; Beheshtkhoo, N., Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Czech Republic |
Liposomes are essentially a subtype of nanoparticles comprising a hydrophobic tail and a hydrophilic head constituting a phospholipid membrane. The spherical or multilayered spherical structures of liposomes are highly rich in lipid contents with numerous criteria for their classification, including structural features, structural parameters, and size, synthesis methods, preparation, and drug loading. Despite various liposomal applications, such as drug, vaccine/gene delivery, biosensors fabrication, diagnosis, and food products applications, their use encounters many limitations due to physico-chemical instability as their stability is vigorously affected by the constituting ingredients wherein cholesterol performs a vital role in the stability of the liposomal membrane. It has well established that cholesterol exerts its impact by controlling fluidity, permeability, membrane strength, elasticity and stiffness, transition temperature (Tm), drug retention, phospholipid packing, and plasma stability. Although the undetermined optimum amount of cholesterol for preparing a stable and controlled release vehicle has been the downside, but researchers are still focused on cholesterol as a promising material for the stability of liposomes necessitating explanation for the stability promotion of liposomes. Herein, the prior art pertaining to the liposomal appliances, especially for drug delivery in cancer therapy, and their stability emphasizing the roles of cholesterol. © Copyright © 2021 Nakhaei, Margiana, Bokov, Abdelbasset, Jadidi Kouhbanani, Varma, Marofi, Jarahian and Beheshtkhoo. |
cholesterol; compounds; lipids; liposome; stability |
Automobile manufacture; Chemical stability; Controlled drug delivery; Food products; Liposomes; Medical applications; Phospholipids; Plasma stability; Targeted drug delivery; Application parameters; Biomedical applications; Compound; Hydrophilic heads; Hydrophobic tails; Liposome structures; Multi-layered; Phospholipid membrane; Spherical structures; Stability parameters; Cholesterol |
Frontiers Media S.A. |
22964185 |
|
|
Review |
Q1 |
1081 |
3891 |
|
|
|
180 |
Marwali E.M., Rayhan M., Roebiono P.S. |
36608535400;57219904946;57192895321; |
Nitroglycerin inhalation for acute treatment of pulmonary arterial hypertension in children with congenital heart disease |
2021 |
Cardiology in the Young |
31 |
9 |
|
1381 |
1385 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107847583&doi=10.1017%2fS1047951121002092&partnerID=40&md5=7d11731cfb6493c4e772840e615e164a |
Pediatric Cardiac Intensive Care Division, National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Division of Pediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia |
Marwali, E.M., Pediatric Cardiac Intensive Care Division, National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Rayhan, M., Pediatric Cardiac Intensive Care Division, National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Roebiono, P.S., Division of Pediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia |
Abstract Objectives: Acute pulmonary hypertension and pulmonary hypertensive crisis may result in adverse clinical outcomes if unsuccessfully treated. Inhaled nitric oxide has long been considered as the standard pharmacotherapy for acute pulmonary hypertension, but lack of feasibility in some settings and evidences challenging its benefits lead to the use of alternative treatment, amongst which is nitroglycerin inhalation. The purpose of this review article is to discuss available data on the use of nitroglycerin inhalation for acute treatment of pulmonary hypertension in children with CHD and its potential benefit in post-operative setting. Data sources: Literatures included in this review were acquired by searching in PubMed online database. Keywords used were Pulmonary Hypertension, Congenital heart defects, Pediatrics, Inhaled nitroglycerin, and its synonyms. Study selection: Title and abstract were screened to select relevant literatures including the three paediatric clinical trials on nitroglycerin inhalation. Critical appraisal of the clinical trials was then done using the University of Oxford Centre of Evidence-Based Medicine Critical Appraisal Tools. Conclusions: Paediatric studies showed the benefit of nitroglycerin inhalation in uncorrected cases of CHD during catheterisation procedures. Until recently, there have been no studies conducted in paediatric post-operative CHD cases. Further study is required to provide evidence for inhaled nitroglycerin use in this setting including the appropriate dosing and potential side effects with repeated administration, © |
aerosolised nitroglycerin; congenital heart disease; corrective surgery; exogenous nitric oxide; Nitroglycerin inhalation; pulmonary arterial hypertension |
glyceryl trinitrate; nitric oxide; phosphodiesterase V inhibitor; prostacyclin; prostacyclin derivative; prostaglandin E1; glyceryl trinitrate; clinical trial (topic); congenital heart disease; drug safety; emergency care; evidence based practice; heart catheterization; human; postoperative care; publication; pulmonary hypertension; Review; child; complication; congenital heart malformation; inhalational drug administration; pulmonary hypertension; Administration, Inhalation; Child; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Nitroglycerin; Pulmonary Arterial Hypertension |
Cambridge University Press |
10479511 |
|
34082850 |
Review |
Q3 |
386 |
12454 |
|
|
|
193 |
Putrantyo I.I., Mosahebi A., Smith O., de Vega B. |
57268843400;55985666400;54881691700;57222467939; |
Investigating Effectiveness of Topical Autologous Platelet-rich Plasma as Prophylaxis to Prevent Wound Infection: A Systematic Review and Meta-analysis |
2021 |
Malaysian Journal of Medicine and Health Sciences |
17 |
|
|
72 |
82 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117073627&partnerID=40&md5=e2542cf5f0470226375c2d3b9af84e52 |
Division of Surgery and Interventional Science, University College London, Royal Free Hospital, London, NW3 2QG, United Kingdom; Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo Hospital, Jakarta Pusat, 10430, Indonesia; Cell and Tissue Bank-Regenerative Medicine Center, Dr Soetomo General Hospital, Surabaya, 60286, Indonesia |
Putrantyo, I.I., Division of Surgery and Interventional Science, University College London, Royal Free Hospital, London, NW3 2QG, United Kingdom, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo Hospital, Jakarta Pusat, 10430, Indonesia; Mosahebi, A., Division of Surgery and Interventional Science, University College London, Royal Free Hospital, London, NW3 2QG, United Kingdom; Smith, O., Division of Surgery and Interventional Science, University College London, Royal Free Hospital, London, NW3 2QG, United Kingdom; de Vega, B., Division of Surgery and Interventional Science, University College London, Royal Free Hospital, London, NW3 2QG, United Kingdom, Cell and Tissue Bank-Regenerative Medicine Center, Dr Soetomo General Hospital, Surabaya, 60286, Indonesia |
Autologous platelet-rich plasma (PRP) was reported as having potent antimicrobial properties. However, the literature showed conflicting results. Therefore, we aim to investigate the effectiveness of topical autologous PRP as prophylaxis to prevent wound infection. We searched major electronic databases such as MEDLINE, EMBASE, CENTRAL, and Web of Science to identify RCT studies regarding this topic. The selection of included studies followed the PRISMA guidelines. We included ten RCTs comprising 1257 participants. In general, PRP showed no effect in reducing the risk of wound infection (RR: 0.84; 95% CI: 0.66–1.06; p=0.14). However, subgroup analysis based on wound characteristic showed that PRP significantly reduced wound infection risks in acute wounds (RR: 0.76; 95% CI: 0.58–0.99; p=0.04). Meanwhile, activation of PRP had no effect in reducing wound infection risks (p=0.77). In conclusion, we suggest routine autologous topical PRP application in acute wound care due to PRP antimicrobial properties and regenerative potential. © 2021 UPM Press. All rights reserved. |
Antimicrobial agent; Platelet-rich plasma; Systematic review; Topical administration; Wound infection |
|
Universiti Putra Malaysia Press |
16758544 |
|
|
Review |
Q4 |
144 |
23823 |
|
|
